Cassava Sciences faces U.S. criminal probe tied to Alzheimer’s drug, sources sayBusiness, R&D, TherapeuticsThe U.S. Justice Department has opened a criminal investigation into Cassava Sciences Inc. involving whether the biotech company manipulated research results for its experimental Alzheimer’s drug, two people familiar with the inquiry said. Read more July 27, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/07/ReutersJusticeDept7-27-2022.jpg 800 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-07-27 06:17:322022-07-27 10:44:16Cassava Sciences faces U.S. criminal probe tied to Alzheimer’s drug, sources say